Verteporfin inhibits papillary thyroid cancer cells proliferation and cell cycle through ERK1/2 signaling pathway.

about

Verteporfin inhibits papillary thyroid cancer cells proliferation and cell cycle through ERK1/2 signaling pathway.

Item

http://www.wikidata.org/entity/Q52714403

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Verteporfin inhibits papillary ...... ough ERK1/2 signaling pathway.

@en

Verteporfin inhibits papillary ...... ough ERK1/2 signaling pathway.

@nl

type

Item

label

Verteporfin inhibits papillary ...... ough ERK1/2 signaling pathway.

@en

Verteporfin inhibits papillary ...... ough ERK1/2 signaling pathway.

@nl

prefLabel

Verteporfin inhibits papillary ...... ough ERK1/2 signaling pathway.

@en

Verteporfin inhibits papillary ...... ough ERK1/2 signaling pathway.

@nl

P1476

Verteporfin inhibits papillary ...... ough ERK1/2 signaling pathway.

@en

P2093

Ben Ma

http://www.w3.org/2001/XMLSchema#string

Duan-Shu Li

http://www.w3.org/2001/XMLSchema#string

Duo Wen

http://www.w3.org/2001/XMLSchema#string

Guo-Hua Sun

http://www.w3.org/2001/XMLSchema#string

Jia-Qian Hu

http://www.w3.org/2001/XMLSchema#string

Jia-Ying Chen

http://www.w3.org/2001/XMLSchema#string

Jun Xiang

http://www.w3.org/2001/XMLSchema#string

Qing Guan

http://www.w3.org/2001/XMLSchema#string

Qing-Hai Ji

http://www.w3.org/2001/XMLSchema#string

Tian Liao

http://www.w3.org/2001/XMLSchema#string

P2860

Phosphorylation of myofibrillogenesis regulator-1 activates the MAPK signaling pathway and induces proliferation and migration in human breast cancer MCF7 cells

Genetic and pharmacological disruption of the TEAD-YAP complex suppresses the oncogenic activity of YAP

Verteporfin-based photodynamic therapy overcomes gemcitabine insensitivity in a panel of pancreatic cancer cell lines.

Phase I/II study of verteporfin photodynamic therapy in locally advanced pancreatic cancer.

Photodynamic therapy with verteporfin: a new treatment in ophthalmology.

NF2 Loss Promotes Oncogenic RAS-Induced Thyroid Cancers via YAP-Dependent Transactivation of RAS Proteins and Sensitizes Them to MEK Inhibition.

YAP activates the Hippo pathway in a negative feedback loop.

Glucose promotes cell proliferation, glucose uptake and invasion in endometrial cancer cells via AMPK/mTOR/S6 and MAPK signaling

Tumor-selective proteotoxicity of verteporfin inhibits colon cancer progression independently of YAP1

EDAG-1 promotes proliferation and invasion of human thyroid cancer cells by activating MAPK/Erk and AKT signal pathways.

P304

1329-1336

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.7150/JCA.21915

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-03-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29721041

http://www.w3.org/2001/XMLSchema#string

P932

5929076

http://www.w3.org/2001/XMLSchema#string